Literature DB >> 6362651

Prostacyclin as an endogenous anti-arrhythmic agent.

U N Das.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6362651     DOI： 10.1007/bf01907219

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN： 0300-8428            Impact factor:   17.165


× No keyword cloud information.
  12 in total

1.  Treatment of the patient after myocardial infarction. The last decade and the next.

Authors:  E Braunwald
Journal:  N Engl J Med       Date:  1980-01-31       Impact factor: 91.245

2.  Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias.

Authors:  S J Coker; J R Parratt; I M Ledingham; I J Zeitlin
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

3.  A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1982-09-16       Impact factor: 91.245

4.  Chronic use of aspirin versus indomethacin during non-thrombotic myocardial ischemia: effects on survival.

Authors:  C B Moschos; B Haider; A J Escobinas; A Gandhi; T J Regan
Journal:  Am Heart J       Date:  1980-11       Impact factor: 4.749

5.  Prostaglandins, thromboxane A2 and cardiovascular drugs.

Authors:  W Förster
Journal:  Pharmazie       Date:  1980-12       Impact factor: 1.267

6.  Prostanoids can modify response to electrical stimulus and 45Ca2+ exchange in isolated myocardial muscle cells.

Authors:  U N Das; A M Lee; G J Barritt
Journal:  Prostaglandins Leukot Med       Date:  1983-11

7.  A selective concentration-dependent dysrhythmogenic and antidysrhythmic action of prostaglandins E2, F2 alpha and I2 (prostacyclin) on isolated rat hearts.

Authors:  M Karmazyn; N S Dhalla
Journal:  Experientia       Date:  1980-08-15

8.  Role of prostaglandins in bronchial asthma.

Authors:  U N Das; M C Padma
Journal:  Med Hypotheses       Date:  1979-12       Impact factor: 1.538

9.  The actions of prostaglandins I2 and E2 on arrhythmias produced by coronary occlusion in the rat and dog.

Authors:  T L Au; G A Collins; C J Harvie; M J Walker
Journal:  Prostaglandins       Date:  1979-11

10.  Possible role of prostaglandins in the pathogenesis of pulmonary hypertension.

Authors:  U N Das
Journal:  Prostaglandins Med       Date:  1980-03
View more
  5 in total

1.  Vagal nerve stimulation in prevention and management of coronary heart disease.

Authors:  Undurti N Das
Journal:  World J Cardiol       Date:  2011-04-26

2.  A defect in Δ6 and Δ5 desaturases may be a factor in the initiation and progression of insulin resistance, the metabolic syndrome and ischemic heart disease in South Asians.

Authors:  Undurti N Das
Journal:  Lipids Health Dis       Date:  2010-11-09       Impact factor: 3.876

3.  Circulating Omega-6, But Not Omega-3 Polyunsaturated Fatty Acids, Are Associated with Clinical Outcomes in Patients with Acute Decompensated Heart Failure.

Authors:  Toshiyuki Nagai; Yasuyuki Honda; Yasuo Sugano; Kunihiro Nishimura; Michikazu Nakai; Satoshi Honda; Naotsugu Iwakami; Atsushi Okada; Yasuhide Asaumi; Takeshi Aiba; Teruo Noguchi; Kengo Kusano; Hisao Ogawa; Satoshi Yasuda; Toshihisa Anzai
Journal:  PLoS One       Date:  2016-11-08       Impact factor: 3.240

4.  Can endogenous lipid molecules serve as predictors and prognostic markers of coronary heart disease?

Authors:  Undurti N Das
Journal:  Lipids Health Dis       Date:  2008-05-20       Impact factor: 3.876

Review 5.  Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules.

Authors:  Undurti N Das
Journal:  Lipids Health Dis       Date:  2008-10-15       Impact factor: 3.876
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.